Table 4 Symptoms of toxicity or withdrawal experienced after SCs use
From: Clinical pattern of synthetic cannabinoids users in Upper Egypt: cross-sectional study
| Number N = 50 | Percentage (%) | |
|---|---|---|
| Neuro-psychiatric effects | ||
| Dizziness/Drowsiness | 34 | 68% |
| Headache | 11 | 22% |
| Seizures | 4 | 8% |
| Irritability/agitation | 2 | 4% |
| Auditory and visual hallucination | 29 | 58% |
| Auditory only hallucination | 2 | 4% |
| Panic attack (fear of death) | 13 | 26% |
| Psychosis | 1 | 2% |
| Cardiovascular effects | ||
| Palpitation | 38 | 76% |
| Chest Pain | 6 | 12% |
| Gastrointestinal effect | ||
| Nausea and vomiting | 12 | 24% |
| Others | ||
| Blurred vision and red eye | 44 | 88% |
| Withdrawal manifestation | 10 | 20% |
| No symptoms were experienced | 2 | 4% |